Harnessing Tandem Mass Spectrometry for Rational Medication Use in Pharmaceutical Sciences
DOI:
https://doi.org/10.56778/rjhs.v2i3.419Keywords:
Tms, Tandem Mass Spectroscopy, Pharmaceutical Sciences, Pharmaceutical Analysis, Spectroscopy,Abstract
Tandem mass spectrometry (TMS) has emerged as a critical analytical tool in pharmaceutical sciences, playing a pivotal role in ensuring the rational use of medications. This article explores the applications of TMS across various stages of drug development, quality assurance, and patient care, highlighting its precision and reliability in advancing therapeutic efficacy. TMS facilitates the accurate identification and quantification of drug compounds, ensuring that pharmaceutical products meet high standards of purity and potency. By detecting even trace levels of impurities or contaminants, TMS strengthens the quality control processes critical to patient safety. In the realm of pharmacokinetics and pharmacodynamics, TMS enables detailed monitoring of drug absorption, distribution, metabolism, and excretion (ADME), allowing for a better understanding of drug behavior in the human body. It is also instrumental in therapeutic drug monitoring (TDM), ensuring that medication levels remain within therapeutic windows, thus optimizing dosing regimens and minimizing adverse effects. Additionally, TMS supports personalized medicine approaches by assessing drug interactions and tailoring treatments to individual patients. Through its application in drug discovery, development, and therapeutic monitoring, TMS serves as an indispensable tool for fostering rational medication use, contributing to more effective, safe, and personalized pharmaceutical care.
References
Baghel, U. S., Singh, A., Singh, D., & Sinha, M. (2017). Application of Mass Spectroscopy in Pharmaceutical and Biomedical Analysis. In E. Sharmin & F. Zafar (Eds.), Spectroscopic Analyses—Developments and Applications. InTech. https://doi.org/10.5772/intechopen.70655
Baker, T. R., & Regg, B. T. (2018). A multi-detector chromatographic approach for characterization and quantitation of botanical constituents to enable in silico safety assessments. Analytical and Bioanalytical Chemistry, 410(21), 5143–5154. https://doi.org/10.1007/s00216-018-1163-y
Birhanu, A. G. (2023). Mass spectrometry-based proteomics as an emerging tool in clinical laboratories. Clinical Proteomics, 20(1), 32. https://doi.org/10.1186/s12014-023-09424-x
De Vijlder, T., Valkenborg, D., Lemière, F., Romijn, E. P., Laukens, K., & Cuyckens, F. (2018). A tutorial in small molecule identification via electrospray ionization‐mass spectrometry: The practical art of structural elucidation. Mass Spectrometry Reviews, 37(5), 607–629. https://doi.org/10.1002/mas.21551
Devaurs, D., Antunes, D. A., & Borysik, A. J. (2022). Computational Modeling of Molecular Structures Guided by Hydrogen-Exchange Data. Journal of the American Society for Mass Spectrometry, 33(2), 215–237. https://doi.org/10.1021/jasms.1c00328
Fang, P., Yu, S., Ma, X., Hou, L., Li, T., Gao, K., Wang, Y., Sun, Q., Shang, L., Liu, Q., Nie, M., & Yang, J. (2024). Applications of tandem mass spectrometry (MS/MS) in antimicrobial peptides field: Current state and new applications. Heliyon, 10(7), e28484. https://doi.org/10.1016/j.heliyon.2024.e28484
Fernandes, D. R., Pereira, V. B., Stelzer, K. T., Gomes, A. O., Neto, F. R. A., & Azevedo, D. A. (2015). Quantification of trace O-containing compounds in GTL process samples via Fischer–Tropsch reaction by comprehensive two-dimensional gas chromatography/mass spectrometry. Talanta, 144, 627–635. https://doi.org/10.1016/j.talanta.2015.06.022
Fung, A. W. S., Sugumar, V., Ren, A. H., & Kulasingam, V. (2020). Emerging role of clinical mass spectrometry in pathology. Journal of Clinical Pathology, 73(2), 61–69. https://doi.org/10.1136/jclinpath-2019-206269
Khalikova, M., Jireš, J., Horáček, O., Douša, M., Kučera, R., & Nováková, L. (2024). What is the role of current mass spectrometry in pharmaceutical analysis? Mass Spectrometry Reviews, 43(3), 560–609. https://doi.org/10.1002/mas.21858
Liang, W. S., Beaulieu-Jones, B., Smalley, S., Snyder, M., Goetz, L. H., & Schork, N. J. (2024). Emerging therapeutic drug monitoring technologies: Considerations and opportunities in precision medicine. Frontiers in Pharmacology, 15, 1348112. https://doi.org/10.3389/fphar.2024.1348112
Liu, Y., Wang, Y., Wang, M., Zhai, S., Hou, C., Sun, F., & Jian, L. (2025). Evaluating biosimilars: Safety, efficacy, and regulatory considerations in clinical studies. International Journal of Clinical Pharmacy, 47(1), 232–236. https://doi.org/10.1007/s11096-024-01825-8
Ma, X. (2022). Recent Advances in Mass Spectrometry-Based Structural Elucidation Techniques. Molecules, 27(19), 6466. https://doi.org/10.3390/molecules27196466
Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N. (2024). Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics, 16(3), 332. https://doi.org/10.3390/pharmaceutics16030332
Neagu, A.-N., Jayathirtha, M., Baxter, E., Donnelly, M., Petre, B. A., & Darie, C. C. (2022). Applications of Tandem Mass Spectrometry (MS/MS) in Protein Analysis for Biomedical Research. Molecules, 27(8), 2411. https://doi.org/10.3390/molecules27082411
Nguyen, T. V., Trang, P. N., & Kumar, A. (2024). Understanding PFAS toxicity through cell culture metabolomics: Current applications and future perspectives. Environment International, 186, 108620. https://doi.org/10.1016/j.envint.2024.108620
Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J., Carpenter, L. L., Cincotta, M., Chen, R., Daskalakis, J. D., Di Lazzaro, V., Fox, M. D., George, M. S., Gilbert, D., Kimiskidis, V. K., Koch, G., Ilmoniemi, R. J., Lefaucheur, J. P., Leocani, L., … Hallett, M. (2021). Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clinical Neurophysiology, 132(1), 269–306. https://doi.org/10.1016/j.clinph.2020.10.003
Son, A., Kim, W., Park, J., Park, Y., Lee, W., Lee, S., & Kim, H. (2024). Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine. International Journal of Molecular Sciences, 25(18), 9880. https://doi.org/10.3390/ijms25189880
Tamara, S., Den Boer, M. A., & Heck, A. J. R. (2022). High-Resolution Native Mass Spectrometry. Chemical Reviews, 122(8), 7269–7326. https://doi.org/10.1021/acs.chemrev.1c00212
Van Rooij, S. J. H., Arulpragasam, A. R., McDonald, W. M., & Philip, N. S. (2024). Accelerated TMS - moving quickly into the future of depression treatment. Neuropsychopharmacology, 49(1), 128–137. https://doi.org/10.1038/s41386-023-01599-z
Wesdemiotis, C., Williams‐Pavlantos, K. N., Keating, A. R., McGee, A. S., & Bochenek, C. (2024). Mass spectrometry of polymers: A tutorial review. Mass Spectrometry Reviews, 43(3), 427–476. https://doi.org/10.1002/mas.21844
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 RADINKA JOURNAL OF HEALTH SCIENCE
This work is licensed under a Creative Commons Attribution 4.0 International License.
<meta name="google-site-verification" content="qBtkk8rnBm0ZRgy_14UYrahahLnkC844dKsDOFjzrn4" />
